Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know.
作者信息
Diotallevi F, Campanati A, Radi G, Martina E, Rizzetto G, Barbadoro P, D'Errico M M, Offidani A
机构信息
Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy.
Department of Biomedical Sciences and Public Health, Section of Hygiene, Preventive Medicine and Public Health, Polytechnic University of the Marche Region, Ancona, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e428-e430. doi: 10.1111/jdv.17256. Epub 2021 Apr 17.
Abstract
摘要
相似文献
1
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的疫苗接种与银屑病：每位皮肤科医生都应了解的三件事。
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e428-e430. doi: 10.1111/jdv.17256. Epub 2021 Apr 17.
2
Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments.关于接受全身治疗的慢性斑块状银屑病患者接种新型冠状病毒疫苗的见解。
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e361-e362. doi: 10.1111/jdv.17200. Epub 2021 Mar 14.
3
COVID-19 vaccines: What dermatologists should know?新型冠状病毒肺炎（COVID-19）疫苗：皮肤科医生应该了解哪些信息？
Dermatol Ther. 2021 Sep;34(5):e15056. doi: 10.1111/dth.15056. Epub 2021 Jul 13.
4
A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?一项关于 COVID-19 合并症的荟萃分析：哪些疾病会增加 SARS-CoV-2 感染的易感性？
Comput Biol Med. 2021 Mar;130:104219. doi: 10.1016/j.compbiomed.2021.104219. Epub 2021 Jan 16.
5
SARS-CoV-2 vaccination status and adverse events among patients with psoriasis-Data from the German Registries PsoBest and CoronaBest.银屑病患者中SARS-CoV-2疫苗接种状况及不良事件——来自德国PsoBest和CoronaBest登记处的数据
J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e831-e833. doi: 10.1111/jdv.19039. Epub 2023 Mar 27.
6
Facial Abrikosoff tumour: The role of the dermatologist during COVID-19 pandemic.面部阿布里科索夫瘤：皮肤科医生在新冠疫情期间的作用
Int Wound J. 2020 Dec;17(6):2026-2027. doi: 10.1111/iwj.13431. Epub 2020 Jun 23.
7
Treatment of psoriasis - unburdened by fear during SARS-CoV2 menace.银屑病治疗——在 SARS-CoV2 威胁下不再恐惧。
J Dermatolog Treat. 2022 Mar;33(2):662-665. doi: 10.1080/09546634.2020.1788704. Epub 2020 Jul 3.
8
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.针对 COVID-19 疫苗接种者和未接种者的严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）抗体：来自同一制造商的两种不同商业可用血清学检测方法的比较方法。
Clin Chim Acta. 2021 Jul;518:9-16. doi: 10.1016/j.cca.2021.03.007. Epub 2021 Mar 17.
9
Employing dermatologists on the frontline against COVID-19: All hands on deck.让皮肤科医生投身抗击新冠疫情的一线：全员出动。
Dermatol Ther. 2020 Sep;33(5):e13420. doi: 10.1111/dth.13420. Epub 2020 May 13.
10
[Current state of vaccination against SARS-CoV-2].[新型冠状病毒2型（SARS-CoV-2）疫苗接种的现状]
Z Rheumatol. 2021 Mar;80(2):158-164. doi: 10.1007/s00393-021-00966-9. Epub 2021 Feb 2.
引用本文的文献
1
Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review.银屑病合并症生物制剂研究进展：文献综述
Clin Cosmet Investig Dermatol. 2023 Dec 4;16:3487-3495. doi: 10.2147/CCID.S439110. eCollection 2023.
2
Management of Infections in Psoriatic Patients Treated with Systemic Therapies: A Lesson from the Immunopathogenesis of Psoriasis.接受系统治疗的银屑病患者感染的管理：来自银屑病免疫发病机制的启示
Dermatol Pract Concept. 2023 Jan 1;13(1):e2023016. doi: 10.5826/dpc.1301a16.
3
Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives.儿童银屑病的生物治疗：现状与未来展望。
Int J Mol Sci. 2022 Sep 22;23(19):11128. doi: 10.3390/ijms231911128.
4
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review.新型冠状病毒疫苗接种后银屑病的新发和恶化：系统评价。
Am J Clin Dermatol. 2022 Nov;23(6):775-799. doi: 10.1007/s40257-022-00721-z. Epub 2022 Sep 1.
5
Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.银屑病的流行病学和合并症：一篇叙述性综述。
Front Immunol. 2022 Jun 10;13:880201. doi: 10.3389/fimmu.2022.880201. eCollection 2022.
6
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities.2019年冠状病毒病大流行期间中重度银屑病的治疗：经验教训与机遇
J Clin Med. 2022 Apr 26;11(9):2422. doi: 10.3390/jcm11092422.
7
SARS-CoV-2 vaccination and practical points in psoriasis patients: A narrative review.SARS-CoV-2 疫苗接种与银屑病患者的实际问题：叙述性综述。
Dermatol Ther. 2022 May;35(5):e15430. doi: 10.1111/dth.15430. Epub 2022 Mar 22.
8
A Web-Based Survey on Factors for Unvaccination and Adverse Reactions of SARS-CoV-2 Vaccines in Chinese Patients with Psoriasis.一项关于中国银屑病患者未接种新冠病毒疫苗的因素及疫苗不良反应的网络调查。
J Inflamm Res. 2021 Nov 27;14:6265-6273. doi: 10.2147/JIR.S341429. eCollection 2021.
9
Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.新型冠状病毒疫苗接种引起的皮肤和过敏反应：综述。
J Cosmet Dermatol. 2022 Jan;21(1):4-12. doi: 10.1111/jocd.14613. Epub 2021 Nov 17.
10
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules.如何应对慢性和免疫介导性皮肤病患者对 SARS-CoV-2 疫苗的犹豫：四项总则。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4105-4107. doi: 10.1080/21645515.2021.1967043. Epub 2021 Oct 1.
本文引用的文献
1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)?银屑病与2019冠状病毒病风险：血管紧张素转换酶（ACE）起作用吗？
J Dermatolog Treat. 2022 Mar;33(2):1175-1176. doi: 10.1080/09546634.2020.1782819. Epub 2020 Jun 30.
4
Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.皮肤科医生在“新冠疫情时代”的积极意义：个人经验与文献回顾。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1626-1632. doi: 10.1111/jdv.16646.
5
Skin involvement in SARS-CoV-2 infection: Case series.新型冠状病毒2型感染中的皮肤表现：病例系列
J Med Virol. 2020 Nov;92(11):2332-2334. doi: 10.1002/jmv.26012. Epub 2020 Jun 2.
6
Global coronavirus pandemic (2019-nCOV): implication for an Italian medium size dermatological clinic of a II level hospital.全球冠状病毒大流行（2019 - 新型冠状病毒）：对一家二级医院的意大利中型皮肤科诊所的影响
J Eur Acad Dermatol Venereol. 2020 May;34(5):e213-e214. doi: 10.1111/jdv.16386.
7
Angiotensin-converting enzyme and subclinical atherosclerosis in psoriasis: Is there any association? A case-control study.银屑病中的血管紧张素转换酶与亚临床动脉粥样硬化：是否存在关联？一项病例对照研究。
J Am Acad Dermatol. 2020 Apr;82(4):980-981.e1. doi: 10.1016/j.jaad.2018.08.003. Epub 2018 Aug 14.
8
Serum and tissue angiotensin converting enzyme in patients with psoriasis.银屑病患者的血清和组织血管紧张素转换酶
Coll Antropol. 2008 Dec;32(4):1215-9.
Zotero 插件